High variability in baseline urinary free cortisol values in patients with Cushing's disease

Clinical Endocrinology

Volumn 80, Issue 2, 2014, Pages 261-269

  Petersenn, Stephan ^a   Newell Price, J ^b   Findling, J W ^c   Gu, F ^d   Maldonado, M ^e   Sen, K ^e   Salgado, L R ^f   Colao, A ^g   Biller, B M K ^h  

^a ENDOC Center for Endocrine Tumors   (Germany)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e NOVARTIS PHARMA AG   (Switzerland)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN;

ACCURACY; ADULT; ARTICLE; BODY MASS; CELL FUNCTION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORTICOTROPIN BLOOD LEVEL; CREATININE URINE LEVEL; CUSHING DISEASE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOTHERAPY; SITTING; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ADULT; AGED; CUSHING SYNDROME; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; RECURRENCE; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SOMATOSTATIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891858213     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12259     Document Type: Article

References (29)

1. Bertagna, X., Guignat, L., Groussin, L., et al,. (2009) Cushing's disease. Best Practice and Research Clinical Endocrinology and Metabolism, 23, 607-623.
2. Newell-Price, J., Bertagna, X., Grossman, A.B., et al,. (2006) Cushing's syndrome. The Lancet, 367, 1605-1617. (Pubitemid 43674231)
3. Clayton, R.N., Raskauskiene, D., Reulen, R.C., et al,. (2011) Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. Journal of Clinical Endocrinology and Metabolism, 96, 632-642.
4. Webb, S.M., Badia, X., Barahona, M.J., et al,. (2008) Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. European Journal of Endocrinology, 158, 623-630. (Pubitemid 351639599)
5. Etxabe, J., &, Vazquez, J.A., (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical Endocrinology, 40, 479-484. (Pubitemid 24194645)
6. Dekkers, O.M., Biermasz, N.R., Pereira, A.M., et al,. (2007) Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. Journal of Clinical Endocrinology and Metabolism, 92, 976-981. (Pubitemid 46465672)
7. Swearingen, B., Biller, B.M., Barker, F.G., et al,. (1999) Long-term mortality after transsphenoidal surgery for Cushing disease. Annals of Internal Medicine, 130, 821-824. (Pubitemid 29231150)
8. Boscaro, M., &, Arnaldi, G., (2009) Approach to the patient with possible Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 94, 3121-3131.
9. Nieman, L.K., Biller, B.M., Findling, J.W., et al,. (2008) The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 93, 1526-1540. (Pubitemid 351656485)
10. Elamin, M.B., Murad, M.H., Mullan, R., et al,. (2008) Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. Journal of Clinical Endocrinology and Metabolism, 93, 1553-1562. (Pubitemid 351656487)
11. Pivonello, R., De Martino, M.C., Cappabianca, P., et al,. (2009) The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. Journal of Clinical Endocrinology and Metabolism, 94, 223-230.
12. Godbout, A., Manavela, M.P., Danilowicz, K., et al,. (2010) Cabergoline monotherapy in the long-term treatment of Cushing's disease. European Journal of Endocrinology, 163, 709-716.
13. Colao, A., Petersenn, S., Newell-Price, J., et al,. (2012) A 12-month Phase 3 study of pasireotide in Cushing's disease. The New England Journal of Medicine, 366, 914-924.
14. Oldfield, E.H., Doppman, J.L., Nieman, L.K., et al,. (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. The New England Journal of Medicine, 325, 897-905.
15. Malerbi, D.A., Mendonca, B.B., Liberman, B., et al,. (1993) The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clinical Endocrinology, 38, 463-472. (Pubitemid 23153407)
16. Turpeinen, U., Markkanen, H., Valimaki, M., et al,. (1997) Determination of urinary free cortisol by HPLC. Clinical Chemistry, 43, 1386-1391. (Pubitemid 27329786)
17. Quan, H., &, Shih, W.J., (1996) Assessing reproducibility by the within-subject coefficient of variation with random effects models. Biometrics, 52, 1195-1203. (Pubitemid 26425271)
18. Besemer, F., Pereira, A.M., &, Smit, J.W., (2011) Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse. The Netherlands Journal of Medicine, 69, 318-323.
19. Invitti, C., Pecori Giraldi, F., Dubini, A., et al,. (1991) Increased urinary free cortisol and decreased serum corticosteroid-binding globulin in polycystic ovary syndrome. Acta Endocrinologica (Copenhagen), 125, 28-32.
20. Vierhapper, H., Kiss, A., Nowotny, P., et al,. (1990) Metabolism of cortisol in anorexia nervosa. Acta Endocrinologica (Copenhagen), 122, 753-758. (Pubitemid 20220423)
21. Viardot, A., Huber, P., Puder, J.J., et al,. (2005) Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. Journal of Clinical Endocrinology and Metabolism, 90, 5730-5736. (Pubitemid 41415483)
22. Starkman, M.N., Giordani, B., Berent, S., et al,. (2001) Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosomatic Medicine, 63, 985-993. (Pubitemid 33101385)
23. Sonino, N., Fava, G.A., Raffi, A.R., et al,. (1998) Clinical correlates of major depression in Cushing's disease. Psychopathology, 31, 302-306. (Pubitemid 28497657)
24. Bakker, R.C., Gallas, P.R., Romijn, J.A., et al,. (1998) Cushing's syndrome complicated by multiple opportunistic infections. Journal of Endocrinological Investigation, 21, 329-333. (Pubitemid 28305964)
25. Graham, B.S., &, Tucker, W.S. Jr, (1984) Opportunistic infections in endogenous Cushing's syndrome. Annals of Internal Medicine, 101, 334-338. (Pubitemid 14033781)
26. Del Dotto, P., &, Bonuccelli, U., (2003) Clinical pharmacokinetics of cabergoline. Clinical Pharmacokinetics, 42, 633-645. (Pubitemid 36936528)
27. Pecori Giraldi, F., Moro, M., &, Cavagnini, F., (2003) Gender-related differences in the presentation and course of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 88, 1554-1558. (Pubitemid 36623369)
28. Findling, J.W., Pinkstaff, S.M., Shaker, J.L., et al,. (1998) Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. The Endocrinologist, 8, 51-54. (Pubitemid 28180292)
29. Meikle, A.W., Findling, J., Kushnir, M.M., et al,. (2003) Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. Journal of Clinical Endocrinology and Metabolism, 88, 3521-3524. (Pubitemid 37034489)